These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11833567)

  • 1. IRBs and Humanitarian Device Exemptions (HDEs).
    Maloney DM
    Hum Res Rep; 2001 Sep; 16(9):4. PubMed ID: 11833567
    [No Abstract]   [Full Text] [Related]  

  • 2. HIPAA and what institutional review boards (IRBs) do not have to review.
    Maloney DM
    Hum Res Rep; 2003 Dec; 18(12):1-2. PubMed ID: 15027429
    [No Abstract]   [Full Text] [Related]  

  • 3. Innovative tools, regulatory bodies, and the creative surgeon.
    Reilly JS
    Arch Otolaryngol Head Neck Surg; 2003 Jun; 129(6):678. PubMed ID: 12810478
    [No Abstract]   [Full Text] [Related]  

  • 4. Interviews that do not require review by IRBs.
    Maloney DM
    Hum Res Rep; 2003 Dec; 18(12):3. PubMed ID: 15027430
    [No Abstract]   [Full Text] [Related]  

  • 5. Agency proposes to combat "IRB shopping" with a new regulation.
    Maloney DM
    Hum Res Rep; 2002 Apr; 17(4):1-2. PubMed ID: 12374178
    [No Abstract]   [Full Text] [Related]  

  • 6. IRBs and the new rule on research with children.
    Maloney DM
    Hum Res Rep; 2002 Jan; 17(1):4. PubMed ID: 16270437
    [No Abstract]   [Full Text] [Related]  

  • 7. When informed consent is not required in studies.
    Maloney DM
    Hum Res Rep; 2006 Jun; 21(6):3. PubMed ID: 17111532
    [No Abstract]   [Full Text] [Related]  

  • 8. IRBs and continuing review: regulatory interference or vital safeguard?
    McBride LC; Yessian MR
    Food Drug Cosmet Med Device Law Dig; 1999 Mar; 16(1):13-7. PubMed ID: 12784812
    [No Abstract]   [Full Text] [Related]  

  • 9. Institutional review board approval for clinical application of new medical devices rather than government agency.
    Nosé Y
    Artif Organs; 2004 Dec; 28(12):1057-8. PubMed ID: 15554932
    [No Abstract]   [Full Text] [Related]  

  • 10. Continued concern: human subject protection, the institutional review board, and continuing review.
    Hoffman S
    Tenn Law Rev; 2001; 68(4):725-70. PubMed ID: 16189912
    [No Abstract]   [Full Text] [Related]  

  • 11. New review burdens will affect many institutional review boards (IRBs).
    Maloney DM
    Hum Res Rep; 2001 Jul; 16(7):9. PubMed ID: 11933956
    [No Abstract]   [Full Text] [Related]  

  • 12. New privacy rule has more tasks for IRBs.
    Maloney DM
    Hum Res Rep; 2001 Feb; 16(2):4. PubMed ID: 12530379
    [No Abstract]   [Full Text] [Related]  

  • 13. Institutional review boards (IRBs) failed to use steps to protect vulnerable research subjects.
    Maloney DM
    Hum Res Rep; 2003 Jun; 18(6):6-7. PubMed ID: 15119342
    [No Abstract]   [Full Text] [Related]  

  • 14. Roles and actions of IRBs as it relates to the process of drug and device development.
    Silverstein JH; Bienstock C
    Mt Sinai J Med; 2008; 75(1):59-62. PubMed ID: 18306252
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioethical malpractice: risk and responsibilities in human research.
    Noah BA
    J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441
    [No Abstract]   [Full Text] [Related]  

  • 16. Institutional review boards (IRBs) and risk considerations for children.
    Maloney DM
    Hum Res Rep; 2004 Sep; 19(9):1-3. PubMed ID: 15675081
    [No Abstract]   [Full Text] [Related]  

  • 17. The FDA's humanitarian device exemption program.
    Eydelman MB; Chen EA
    Health Aff (Millwood); 2011 Jun; 30(6):1210-2; author reply 1212. PubMed ID: 21653975
    [No Abstract]   [Full Text] [Related]  

  • 18. A humanitarian device exemption for deep brain stimulation.
    Alpert S
    Health Aff (Millwood); 2011 Jun; 30(6):1212; author reply 1212. PubMed ID: 21653977
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
    Saver RS
    William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
    [No Abstract]   [Full Text] [Related]  

  • 20. Recruiting human subjects without IRB review/approval.
    Maloney DM
    Hum Res Rep; 2002 Aug; 17(8):3. PubMed ID: 12731493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.